[1]
2026. HYDROXYUREA TREATMENT AND REDUCTION IN TRANSFUSION DEMAND IN Β-THALASSEMIA MAJOR: EVIDENCE FROM THE HOSPITAL-BASED STUDY IN KARACHI. Bioscience Insights. 3, 02 (Aug. 2026), 351–361.